International Health Management Associates provides a full suite of technical capabilities and domain expertise in all phases of antimicrobial drug development.
- Tweets251
- Following21
- Followers44
- Likes49
ALT "Fighting Antimicrobial Resistance Takes All of Us" November 18-24, 2024
ALT Handle Antimicrobials with Care Antibiotics, Antivirals, Antifungals, Antiparasitics
ALT “Educate. Advocate. Act now.” Image of microbiologist holding and pointing to culture plates Logos for: Food and Agriculture Organization of the United Nations, UN Environment Programme, World Health Organization, and World Organisation for Animal Health
ALT IDWeek 2024 Presentation Schedule Los Angeles, California | 16 – 19 October 2024 Thursday, October 17th | 12:15 PM – 1:30 PM US PT | Halls J & K Poster Session: N13. Health Care-Associated Infections: Non-Bacterial (Fungal, Viral) (1 poster: P-352) Friday, October 18th | 12:15 PM – 1:30 PM US PT | Halls J & K :15 PM – 1:30 PM US PT | Halls J & K Poster Session: A2. PK/PD studies (1 poster: P-1229) Poster Session: A3. Resistance mechanisms (1 poster: P-1355) Poster Session: A4. Treatment of antimicrobial resistant infections (13 posters: P-1506, P-1507, P-1508, P-1509, P-1510, P-1511, P-1513, P-1514, P-1518, P-1519, P-1520, P-1521, P-1532)
ALT Saturday, October 19th | 12:15 PM – 1:30 PM US PT | Halls J & K Poster Session: D1. Diagnostics: Bacteriology/mycobacteriology (1 poster: P-2102) Your Global Antimicrobial Partner IHMA supports all phases of anti-infective therapy development, from discovery through commercialization. We are your essential resource for central, reference, and clinical research laboratory services worldwide. IHMA supports companies needing: • Pre-clinical studies for regulatory filings • Global laboratory services for all phases of clinical trials • Antimicrobial resistance (AMR) surveillance (bacterial and fungal) • Molecular characterization and detection of infectious agents • New therapeutic approaches (bacteriophage, vaccine, etc.) • In vitro diagnostic device studies
ALT Pictured: Entryway installation of the IDWeek logo atop a globe displayed as you enter into the Los Angeles Convention center
ALT IDWeek 2024 Presentation Schedule Los Angeles, California | 16 – 19 October 2024 Thursday, October 17th | 12:15 PM – 1:30 PM US PT | Halls J & K Poster Session: N13. Health Care-Associated Infections: Non-Bacterial (Fungal, Viral) (1 poster: P-352) Friday, October 18th | 12:15 PM – 1:30 PM US PT | Halls J & K :15 PM – 1:30 PM US PT | Halls J & K Poster Session: A2. PK/PD studies (1 poster: P-1229) Poster Session: A3. Resistance mechanisms (1 poster: P-1355) Poster Session: A4. Treatment of antimicrobial resistant infections (13 posters: P-1506, P-1507, P-1508, P-1509, P-1510, P-1511, P-1513, P-1514, P-1518, P-1519, P-1520, P-1521, P-1532)
ALT Saturday, October 19th | 12:15 PM – 1:30 PM US PT | Halls J & K Poster Session: D1. Diagnostics: Bacteriology/mycobacteriology (1 poster: P-2102) Your Global Antimicrobial Partner IHMA supports all phases of anti-infective therapy development, from discovery through commercialization. We are your essential resource for central, reference, and clinical research laboratory services worldwide. IHMA supports companies needing: • Pre-clinical studies for regulatory filings • Global laboratory services for all phases of clinical trials • Antimicrobial resistance (AMR) surveillance (bacterial and fungal) • Molecular characterization and detection of infectious agents • New therapeutic approaches (bacteriophage, vaccine, etc.) • In vitro diagnostic device studies
ALT IDWeek 2024 16 – 19 October 2024 Los Angeles, California 17 Total Poster Presentations Meet the IHMA Team! Stephen Hawser, PhD: CEO, IHMA Europe Sàrl Brian Johnson: Vice President, Operations Darcie Carpenter, PhD, CIC: Director, Business Development Image: Los Angeles skyline at dusk
ALT Meet the IHMA Team at the ESCMID/ASM Joint Conference Meet the Challenge of Antimicrobial Resistance 17–20 September 2024 Porto, Portugal Pictured: Stephen Hawser, PhD: CEO, IHMA Europe Sàrl Darcie Carpenter, PhD, CIC: Director, Business Development Above text overlaid on an image of Porto’s Douro River and the Luís I Bridge.
ALT Meet the IHMA Team at the ESCMID/ASM Joint Conference Meet the Challenge of Antimicrobial Resistance 17–20 September 2024 Porto, Portugal Pictured: Stephen Hawser, PhD: CEO, IHMA Europe Sàrl Darcie Carpenter, PhD, CIC: Director, Business Development Above text overlaid on an image of Porto’s colorful, historic buildings along the Douro River.
ALT Image of meeting entry sign: "Subcommittee on Antimicrobial Susceptibility Testing (AST)" with CLSI logo on blue background
ALT Join IHMA at the 34th ESCMID Global Congress Barcelona, Spain 27 – 30 April 2024 38 Total Poster Presentations Meet the IHMA Team at Booth #E67 Images of IHMA attendees: Stephen Hawser, PhD CEO, IHMA Europe Sàrl Brian Johnson Vice President, Operations Darcie Carpenter, PhD, CIC Director, Business Development
